HomeBlood Pressure ManagementBlood Pressure MedicationsTEVETEN® HCT ...

TEVETEN® HCT (eprosartan mesylate/hydrochlorothiazide)

TEVETEN® HCT (eprosartan mesylate/hydrochlorothiazide) is a combined ARB and diuretic (hydrochlorothiazide) indicated for the treatment of hypertension. Usual recommended starting dose: 600mg/12.5mg once daily when used as combination therapy in patients who are not volume-depleted. Recommended dose range: 600mg/12.5mg to 600mg/25mg. Active Ingredients: eprosartan mesylate, hydrochlorothiazide.

How Supplied/Sizing

Tablet: 600mg eprosartan/12.5mg HCTZ; 600mg eprosartan/25mg HCTZ.

Company Information

Abbott Laboratories

Street:
Pharmaceutical Products Division
Additional:
100 Abbott Park Rd.
City:
Abbott Park
,
Province:
Illinois
Postal Code:
60064-3500
Country:
United States

Broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health.

Website: 
www.abbott.com
Phone: 
847-937-6100

Product Features

Contact manufacturer for further details●

Post new comment

Post a regular comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <img> <h2> <h3> <h4> <i> <b> <pre>
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.